PRINCIPIA BIOPHARMA INC. Operating Expenses
PRINCIPIA BIOPHARMA INC. reported Operating Expenses of $40.12 million for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2020-08-06
- PRINCIPIA BIOPHARMA INC. operating expenses for the quarter ending 2020-06-30 was $40.12M, a 67.50% increase year-over-year.
- PRINCIPIA BIOPHARMA INC. operating expenses for the quarter ending 2020-03-31 was $34.11M, a 70.29% increase year-over-year.
- PRINCIPIA BIOPHARMA INC. operating expenses for the quarter ending 2019-12-31 was $26.61M, a 48.87% increase year-over-year.
- PRINCIPIA BIOPHARMA INC. operating expenses for the quarter ending 2019-09-30 was $23.33M, a 93.04% increase year-over-year.
- PRINCIPIA BIOPHARMA INC. operating expenses for fiscal 2019 was $93.92M, a 80.64% increase from fiscal 2018.
- PRINCIPIA BIOPHARMA INC. operating expenses for fiscal 2018 was $51.99M, a 63.34% increase from fiscal 2017.
- PRINCIPIA BIOPHARMA INC. operating expenses for fiscal 2017 was $31.83M, a 17.67% increase from fiscal 2016.
- PRINCIPIA BIOPHARMA INC. operating expenses for fiscal 2016 was $27.05M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2020-06-30 | $40.12M 10-Q · filed 2020-08-06 | $74.23M 10-Q · filed 2020-08-06 | $100.84M derived: sum of 3 quarters · filed 2020-08-06 | $124.17M derived: sum of 4 quarters · filed 2020-08-06 |
| 2020-03-31 | $34.11M 10-Q · filed 2020-05-06 | $60.72M derived: sum of 2 quarters · filed 2020-05-06 | $84.06M derived: sum of 3 quarters · filed 2020-05-06 | $108.01M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-12-31 | $26.61M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $49.94M derived: sum of 2 quarters · filed 2020-03-10 | $73.89M derived: sum of 3 quarters · filed 2020-08-06 | $93.92M 10-K · filed 2020-03-10 |
| 2019-09-30 | $23.33M 10-Q · filed 2019-11-05 | $47.28M derived: sum of 2 quarters · filed 2020-08-06 | $67.31M 10-Q · filed 2019-11-05 | $85.19M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-06-30 | $23.95M 10-Q · filed 2020-08-06 | $43.98M 10-Q · filed 2020-08-06 | $61.86M derived: sum of 3 quarters · filed 2020-08-06 | $73.94M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $20.03M 10-Q · filed 2020-05-06 | $37.91M derived: sum of 2 quarters · filed 2020-05-06 | $49.99M derived: sum of 3 quarters · filed 2020-05-06 | $61.11M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | $17.88M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $29.96M derived: sum of 2 quarters · filed 2020-03-10 | $41.08M derived: sum of 3 quarters · filed 2020-03-10 | $51.99M 10-K · filed 2020-03-10 |
| 2018-09-30 | $12.09M 10-Q · filed 2019-11-05 | $23.20M derived: sum of 2 quarters · filed 2019-11-05 | $34.12M 10-Q · filed 2019-11-05 | $43.68M derived: sum of 4 quarters · filed 2020-03-10 |
| 2018-06-30 | $11.12M 10-Q · filed 2019-08-08 | $22.03M 10-Q · filed 2019-08-08 | $31.59M derived: sum of 3 quarters · filed 2020-03-10 | $38.98M derived: sum of 4 quarters · filed 2020-03-10 |
| 2018-03-31 | $10.92M 10-Q · filed 2019-05-07 | $20.47M derived: sum of 2 quarters · filed 2020-03-10 | $27.86M derived: sum of 3 quarters · filed 2020-03-10 | |
| 2017-12-31 | $9.56M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $16.95M derived: sum of 2 quarters · filed 2020-03-10 | $31.83M 10-K · filed 2020-03-10 | |
| 2017-09-30 | $7.39M 10-Q · filed 2018-11-06 | $22.28M 10-Q · filed 2018-11-06 | ||
| 2016-12-31 | $27.05M 10-K · filed 2019-03-19 |